| H&l Psychological Services, Llc | |
|
2132 S 12th St Ste 402 Allentown PA 18103-4810 | |
| (484) 350-3001 | |
| Not Available |
| Full Name | H&l Psychological Services, Llc |
|---|---|
| Speciality | Psychologist |
| Location | 2132 S 12th St Ste 402, Allentown, Pennsylvania |
| Authorized Official Name and Position | Alison Litman (PSYCHOLOGIST/OWNER) |
| Authorized Official Contact | 4846193079 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| H&l Psychological Services, Llc 2132 S 12th St Ste 402 Allentown PA 18103-4810 Ph: () - | H&l Psychological Services, Llc 2132 S 12th St Ste 402 Allentown PA 18103-4810 Ph: (484) 350-3001 |
| NPI Number | 1811419666 |
|---|---|
| Provider Enumeration Date | 07/13/2017 |
| Last Update Date | 02/25/2020 |
| Certification Date | 02/25/2020 |
| Medicare PECOS PAC ID | 4587936570 |
|---|---|
| Medicare Enrollment ID | O20170825002494 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.
On Friday, October 2, 2009, Alberta Health Services and the Alberta Children's Hospital Foundation will host an Open House and "House Warming" Celebration for Rotary/Flames House - the first hospice for children in this province. The facility is only the sixth of its kind in North America and will help families caring for children with progressive and life-threatening illnesses.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811419666 | NPI | - | NPPES |
| 003627391 | Other | HIGHMARK/BCBS | |
| 1033499710001 | Medicaid | PA | |
| 1033499710002 | Medicaid | PA | |
| 50154644 | Other | CAPITAL BLUE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Farah A Moyer |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1053549790 PECOS PAC ID: 9638201270 Enrollment ID: I20100719000253 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.
On Friday, October 2, 2009, Alberta Health Services and the Alberta Children's Hospital Foundation will host an Open House and "House Warming" Celebration for Rotary/Flames House - the first hospice for children in this province. The facility is only the sixth of its kind in North America and will help families caring for children with progressive and life-threatening illnesses.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 8 days ago
| Provider Name | Alison Litman |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1437693447 PECOS PAC ID: 0840562831 Enrollment ID: I20170825002604 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.
On Friday, October 2, 2009, Alberta Health Services and the Alberta Children's Hospital Foundation will host an Open House and "House Warming" Celebration for Rotary/Flames House - the first hospice for children in this province. The facility is only the sixth of its kind in North America and will help families caring for children with progressive and life-threatening illnesses.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 8 days ago
| Provider Name | Christine Hartigan |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1952706459 PECOS PAC ID: 1759653744 Enrollment ID: I20180312000019 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.
On Friday, October 2, 2009, Alberta Health Services and the Alberta Children's Hospital Foundation will host an Open House and "House Warming" Celebration for Rotary/Flames House - the first hospice for children in this province. The facility is only the sixth of its kind in North America and will help families caring for children with progressive and life-threatening illnesses.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 8 days ago
| Provider Name | Adrienne Jill Baker |
|---|---|
| Provider Type | Practitioner - Other (non-physician) |
| Provider Identifiers | NPI Number: 1427359033 PECOS PAC ID: 7113378902 Enrollment ID: I20240105001478 |
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.
On Friday, October 2, 2009, Alberta Health Services and the Alberta Children's Hospital Foundation will host an Open House and "House Warming" Celebration for Rotary/Flames House - the first hospice for children in this province. The facility is only the sixth of its kind in North America and will help families caring for children with progressive and life-threatening illnesses.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 8 days ago
News Archive
Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.
Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria, a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign.
On Friday, October 2, 2009, Alberta Health Services and the Alberta Children's Hospital Foundation will host an Open House and "House Warming" Celebration for Rotary/Flames House - the first hospice for children in this province. The facility is only the sixth of its kind in North America and will help families caring for children with progressive and life-threatening illnesses.
Researchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system that could ultimately delay the onset of pancreatic cancer. The study provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease and to slow down tumor growth in patients who are affected by it.
Today, The Lancet Neurology published positive results from a sub-group analysis of the landmark Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY®) trial - the largest atrial fibrillation (AF) outcomes trial ever completed (18,113 patients in 44 countries worldwide). The new findings fully support the convincing results from the RE-LY® trial and show that AF patients with previous stroke or transient ischemic attack (TIA) may benefit substantially from treatment with dabigatran etexilate.
› Verified 8 days ago
Lvpg Neuropsychology - 1250 Cedar Crest Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1250 S Cedar Crest Blvd, Suite 410, Allentown, PA 18103 Phone: 610-402-3500 | |
Catholic Charities, Allentown Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 402 Chew St, Allentown, PA 18102 Phone: 610-435-1541 | |
Ida Andrea Olmeda Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1700 Hanover Ave, Allentown, PA 18109 Phone: 484-357-7599 Fax: 610-439-8004 | |
Bayada Home Health Care, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 961 Marcon Blvd Ste 103, Allentown, PA 18109 Phone: 484-795-5920 Fax: 484-795-5921 | |
Jewish Family Service Of The Lehigh Valley Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2004 W Allen St, Allentown, PA 18104 Phone: 610-821-8722 | |
Vitalistic Therapeutic Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1406 W Hamilton St, Allentown, PA 18102 Phone: 610-433-4383 | |
Alicia Coffman Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1011 Brookside Rd Ste 302, Allentown, PA 18106 Phone: 484-809-9366 |